Small molecule grp94 inhibitors block dengue and Zika virus replication

Two major flaviviruses, dengue virus (DENV) and Zika virus (ZIKV), cause severe health and economic burdens worldwide. Recently, genome-wide screenings have uncovered the importance of regulators of the Hrd1 ubiquitin ligase-mediated endoplasmic reticulum (ER)-associated degradation (ERAD) pathway f...

Full description

Saved in:
Bibliographic Details
Main Authors: Rothan, Hussin A., Zhong, Yongwang, Sanborn, Mark A., Teoh, Teow Chong, Ruan, Jingjing, Yusof, Rohana, Hang, Jun, Henderson, Mark J., Fang, Shengyun
Format: Article
Published: Elsevier Masson 2019
Subjects:
Online Access:http://eprints.um.edu.my/23623/
https://doi.org/10.1016/j.antiviral.2019.104590
Tags: Add Tag
No Tags, Be the first to tag this record!
id my.um.eprints.23623
record_format eprints
spelling my.um.eprints.236232020-01-29T04:15:13Z http://eprints.um.edu.my/23623/ Small molecule grp94 inhibitors block dengue and Zika virus replication Rothan, Hussin A. Zhong, Yongwang Sanborn, Mark A. Teoh, Teow Chong Ruan, Jingjing Yusof, Rohana Hang, Jun Henderson, Mark J. Fang, Shengyun QR Microbiology R Medicine Two major flaviviruses, dengue virus (DENV) and Zika virus (ZIKV), cause severe health and economic burdens worldwide. Recently, genome-wide screenings have uncovered the importance of regulators of the Hrd1 ubiquitin ligase-mediated endoplasmic reticulum (ER)-associated degradation (ERAD) pathway for flavivirus replication in host cells. Here we report the identification of the compound Bardoxolone methyl (CDDO-me) as a potent inhibitor of the Hrd1 ubiquitin ligase-mediated ERAD, which possesses a broad-spectrum activity against both DENV and ZIKV. Cellular thermal shift assay (CETSA) suggested that CDDO-me binds to grp94, a key component of the Hrd1 pathway, at a low nanomolar concentration, whereas interaction was not detected with its paralog Hsp90. CDDO-me and the grp94 inhibitor PU-WS13 substantially suppressed DENV2 replication and the cytopathic effects caused by DENV and ZIKV infection. The antiviral activities of both compounds were demonstrated for all four DENV serotypes and four ZIKV strains in multiple human cell lines. This study defines grp94 as a crucial host factor for flavivirus replication and identified CDDO-me as a potent small molecule inhibitor of flavivirus infection. Inhibition of grp94 may contribute to the antiviral activity of CDDO-me. Further investigation of grp94 inhibitors may lead to a new class of broad-spectrum anti-flaviviral medications. © 2019 Elsevier B.V. Elsevier Masson 2019 Article PeerReviewed Rothan, Hussin A. and Zhong, Yongwang and Sanborn, Mark A. and Teoh, Teow Chong and Ruan, Jingjing and Yusof, Rohana and Hang, Jun and Henderson, Mark J. and Fang, Shengyun (2019) Small molecule grp94 inhibitors block dengue and Zika virus replication. Antiviral Research, 171. p. 104590. ISSN 0166-3542 https://doi.org/10.1016/j.antiviral.2019.104590 doi:10.1016/j.antiviral.2019.104590
institution Universiti Malaya
building UM Library
collection Institutional Repository
continent Asia
country Malaysia
content_provider Universiti Malaya
content_source UM Research Repository
url_provider http://eprints.um.edu.my/
topic QR Microbiology
R Medicine
spellingShingle QR Microbiology
R Medicine
Rothan, Hussin A.
Zhong, Yongwang
Sanborn, Mark A.
Teoh, Teow Chong
Ruan, Jingjing
Yusof, Rohana
Hang, Jun
Henderson, Mark J.
Fang, Shengyun
Small molecule grp94 inhibitors block dengue and Zika virus replication
description Two major flaviviruses, dengue virus (DENV) and Zika virus (ZIKV), cause severe health and economic burdens worldwide. Recently, genome-wide screenings have uncovered the importance of regulators of the Hrd1 ubiquitin ligase-mediated endoplasmic reticulum (ER)-associated degradation (ERAD) pathway for flavivirus replication in host cells. Here we report the identification of the compound Bardoxolone methyl (CDDO-me) as a potent inhibitor of the Hrd1 ubiquitin ligase-mediated ERAD, which possesses a broad-spectrum activity against both DENV and ZIKV. Cellular thermal shift assay (CETSA) suggested that CDDO-me binds to grp94, a key component of the Hrd1 pathway, at a low nanomolar concentration, whereas interaction was not detected with its paralog Hsp90. CDDO-me and the grp94 inhibitor PU-WS13 substantially suppressed DENV2 replication and the cytopathic effects caused by DENV and ZIKV infection. The antiviral activities of both compounds were demonstrated for all four DENV serotypes and four ZIKV strains in multiple human cell lines. This study defines grp94 as a crucial host factor for flavivirus replication and identified CDDO-me as a potent small molecule inhibitor of flavivirus infection. Inhibition of grp94 may contribute to the antiviral activity of CDDO-me. Further investigation of grp94 inhibitors may lead to a new class of broad-spectrum anti-flaviviral medications. © 2019 Elsevier B.V.
format Article
author Rothan, Hussin A.
Zhong, Yongwang
Sanborn, Mark A.
Teoh, Teow Chong
Ruan, Jingjing
Yusof, Rohana
Hang, Jun
Henderson, Mark J.
Fang, Shengyun
author_facet Rothan, Hussin A.
Zhong, Yongwang
Sanborn, Mark A.
Teoh, Teow Chong
Ruan, Jingjing
Yusof, Rohana
Hang, Jun
Henderson, Mark J.
Fang, Shengyun
author_sort Rothan, Hussin A.
title Small molecule grp94 inhibitors block dengue and Zika virus replication
title_short Small molecule grp94 inhibitors block dengue and Zika virus replication
title_full Small molecule grp94 inhibitors block dengue and Zika virus replication
title_fullStr Small molecule grp94 inhibitors block dengue and Zika virus replication
title_full_unstemmed Small molecule grp94 inhibitors block dengue and Zika virus replication
title_sort small molecule grp94 inhibitors block dengue and zika virus replication
publisher Elsevier Masson
publishDate 2019
url http://eprints.um.edu.my/23623/
https://doi.org/10.1016/j.antiviral.2019.104590
_version_ 1657488237301596160
score 13.19449